Notice of Republication
This article was republished on March 14, 2016, to correct the captions of Figs 3–7 and Figs 9–10 and figure citations in the Discussion section. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.
Supporting Information
S1 File. Originally published, uncorrected article.
https://doi.org/10.1371/journal.pone.0152845.s001
(PDF)
Reference
Citation: Nagata E, Ogino M, Iwamoto K, Kitagawa Y, Iwasaki Y, Yoshii F, et al. (2016) Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients. PLoS ONE 11(3): e0152845. https://doi.org/10.1371/journal.pone.0152845
Published: March 28, 2016
Copyright: © 2016 Nagata et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.